For generations, the days before a period have been brushed off as moodiness, irritability, or something to simply "get through". But what happens in the luteal phase is real, it is physiological, and in some cases it is disabling. Understanding where ordinary premenstrual changes end and a medical condition begins is essential.
What Is PMS?
Premenstrual syndrome (PMS) refers to a cluster of physical and emotional symptoms that appear in the luteal phase, the roughly two weeks after ovulation, and resolve within a few days of bleeding starting. Up to three in four menstruating people experience some form of PMS.
Common features include:
• Breast tenderness and bloating
• Headaches or migraines
• Fatigue and sleep disturbance
• Irritability, low mood, or anxiety
• Increased appetite or food cravings
• Difficulty concentrating
Symptoms are driven by the dramatic drop in oestrogen and progesterone in the late luteal phase, which affects neurotransmitters including serotonin and GABA. For many, symptoms are mild and manageable. For others, they significantly disrupt daily life.
What Is PMDD?
Premenstrual dysphoric disorder (PMDD) is a severe, clinically recognised form of premenstrual illness that affects an estimated 3 to 8 percent of menstruating people. PMDD is not simply "bad PMS". It is classified as a depressive disorder in the DSM-5 and is characterised by debilitating mood symptoms that appear in the luteal phase and lift within days of menstruation.
Diagnostic features include at least five of the following symptoms during most luteal phases, with at least one being a core mood symptom:
• Marked mood swings or sudden tearfulness
• Marked irritability or anger, often with interpersonal conflict
• Marked depressed mood, feelings of hopelessness, or self-critical thoughts
• Marked anxiety, tension, or a feeling of being on edge
• Loss of interest in usual activities
• Difficulty concentrating
• Lethargy or marked lack of energy
• Changes in appetite, sleep, or a sense of being overwhelmed
PMDD is not caused by abnormal hormone levels. Research increasingly points to an abnormal brain sensitivity to normal hormonal fluctuations, particularly to allopregnanolone, a metabolite of progesterone.
Why It Gets Missed
PMDD is frequently misdiagnosed as generalised anxiety, bipolar II disorder or treatment-resistant depression. The key differentiator is cyclical timing: symptoms appear in the luteal phase and clear during menstruation or the early follicular phase. Tracking symptoms daily across at least two cycles is the gold standard for diagnosis.
What Actually Helps
Evidence-based approaches span several categories:
Lifestyle: Regular aerobic exercise, consistent sleep, reduced alcohol and caffeine in the luteal phase have modest but substantial effects on PMS.
Nutrition: Calcium (around 1,200 mg daily), vitamin B6, and magnesium have supporting evidence. Reducing refined carbohydrates helps stabilise mood.
SSRIs: First-line pharmacological treatment for moderate-to-severe PMS and PMDD, often taken only in the luteal phase rather than continuously.
Hormonal suppression: Combined oral contraceptives (particularly those containing drospirenone) can help. For severe PMDD unresponsive to other treatments, GnRH analogues with add-back therapy may be considered.
Cognitive behavioural therapy: Evidence-based for both PMS and PMDD, particularly for managing the interpersonal and cognitive dimensions.
A Note on Self-Advocacy
If your premenstrual symptoms are disrupting your work, relationships or sense of self, that is not something to wait out. Track your symptoms against your cycle for two to three months, bring the data to a clinician, and ask specifically whether PMDD might apply. Naming it is often the beginning of getting proper care.